Hcr Wealth Advisors Abb Vie Inc. Transaction History

Hcr Wealth Advisors

$757 Million
Q3 2024

A detailed history of Hcr Wealth Advisors transactions in Abb Vie Inc. stock. As of the latest transaction made, Hcr Wealth Advisors holds 14,201 shares of ABBV stock, worth $2.53 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares

14,201

Previous 14,201 -0.0%

Holding current value

$2.53 Million

Previous $2.44 Million 15.15%

% of portfolio

0.37%

Previous 0.35%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	SELL	$154.79 - $180.76 $13,466 - $15,726	-87 Reduced 0.61%	14,201 $2.44 Million
Q1 2024 May 10, 2024	SELL	$159.82 - $182.1 $51,941 - $59,182	-325 Reduced 2.22%	14,288 $2.6 Million
Q4 2023 Feb 09, 2024	BUY	$137.6 - $154.97 $324,185 - $365,109	2,356 Added 19.22%	14,613 $2.26 Million
Q3 2023 Oct 20, 2023	SELL	$133.59 - $154.65 $460,618 - $533,233	-3,448 Reduced 21.95%	12,257 $1.83 Million
Q2 2023 Aug 09, 2023	SELL	$132.51 - $164.9 $68,772 - $85,583	-519 Reduced 3.2%	15,705 $2.12 Million
Q1 2023 May 12, 2023	SELL	$144.61 - $166.54 $52,493 - $60,454	-363 Reduced 2.19%	16,224 $2.59 Million
Q4 2022 Feb 13, 2023	SELL	$138.31 - $165.87 $69,569 - $83,432	-503 Reduced 2.94%	16,587 $2.68 Million
Q3 2022 Nov 07, 2022	SELL	$134.21 - $153.93 $57,978 - $66,497	-432 Reduced 2.47%	17,090 $2.29 Million
Q2 2022 Aug 12, 2022	SELL	$137.62 - $174.96 $39,084 - $49,688	-284 Reduced 1.59%	17,522 $2.68 Million
Q1 2022 May 05, 2022	SELL	$131.98 - $163.75 $1.68 Million - $2.09 Million	-12,762 Reduced 41.75%	17,806 $2.89 Million
Q4 2021 Feb 04, 2022	SELL	$107.43 - $135.93 $119,784 - $151,561	-1,115 Reduced 3.52%	30,568 $4.14 Million
Q3 2021 Nov 02, 2021	BUY	$106.4 - $120.78 $7,980 - $9,058	75 Added 0.24%	31,683 $3.42 Million
Q2 2021 Jul 21, 2021	BUY	$105.21 - $117.21 $107,314 - $119,554	1,020 Added 3.33%	31,608 $3.56 Million
Q1 2021 May 13, 2021	BUY	$102.3 - $112.62 $3.13 Million - $3.44 Million	30,588 New	30,588 $3.31 Million
Q4 2020 Feb 04, 2021	SELL	$80.49 - $108.67 $2.46 Million - $3.32 Million	-30,512 Closed	0 $0
Q3 2020 Nov 05, 2020	BUY	$85.91 - $100.83 $41,580 - $48,801	484 Added 1.61%	30,512 $2.66 Million
Q2 2020 Jul 30, 2020	BUY	$73.37 - $98.18 $2.2 Million - $2.95 Million	30,028 New	30,028 $2.98 Million
Q1 2019 May 10, 2019	SELL	$77.14 - $90.79 $262,970 - $309,503	-3,409 Closed	0 $0
Q4 2018 Jan 31, 2019	BUY	$77.85 - $96.01 $265,390 - $327,298	3,409 New	3,409 $295,000
Q3 2018 Nov 09, 2018	SELL	$88.91 - $98.84 $309,762 - $344,358	-3,484 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$89.78 - $106.23 $2,244 - $2,655	25 Added 0.72%	3,484 $303,000
Q1 2018 May 15, 2018	SELL	$92.01 - $123.21 $276 - $369	-3 Reduced 0.09%	3,459 $308,000
Q4 2017 Feb 13, 2018	BUY	$89.56 - $98.21 $98,874 - $108,423	1,104 Added 46.82%	3,462 $315,000
Q3 2017 Nov 13, 2017	BUY	$69.85 - $89.22 $164,706 - $210,380	2,358	2,358 $210,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $315B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hcr Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Hcr Wealth Advisors with notifications on news.

Account

Hcr Wealth Advisors Abb Vie Inc. Transaction History